Literature DB >> 32603797

The past is not the future in tobacco control.

K Michael Cummings1, Scott Ballin2, David Sweanor3.   

Abstract

In this paper we have attempted to identify missed opportunities to change the trajectory of smoking and smoking caused diseases in America over the past 100 years. Many of the missed opportunities identified are due to the actions of cigarette manufacturers who misled the public about the dangers of cigarette smoking, the addictiveness of nicotine, and the feasibility of providing lower risk alternative nicotine delivery products to addicted smokers. An important lesson learned from the past is that treating all tobacco/nicotine products as equivalently harmful is counterproductive to public health as it only serves to protect the most lethal nicotine product - cigarettes. Since 2000, the evolving marketplace of lower risk nicotine products combined with regulatory authority over tobacco products represents a new opportunity to dramatically transform the cigarette business in ways that were never imagined when the war on tobacco was raging decades ago. However, this requires embracing risk-proportionate regulation, taxation policies, and providing consumers with accurate public messaging on product relative risks. A regulatory framework based on sound science that encourages and rewards new or existing manufacturers to invest in consumer acceptable lower risk products to replace cigarettes needs to be encouraged. The past is indeed not the future in smoking control, but it may be difficult to escape the past unless a realignment of market forces and policies can be achieved.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cigarette smoking prevalence; Electronic cigarettes; Harm reduction; Nicotine addiction; Product regulation; Quit ratios; Smoking cessation; Smoking initiation; Tobacco control

Mesh:

Year:  2020        PMID: 32603797      PMCID: PMC7680276          DOI: 10.1016/j.ypmed.2020.106183

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  44 in total

1.  Assumption of Risk and the Role of Health Warnings Labels in the United States.

Authors:  K Michael Cummings; Jonathan Gdanski; Nichole Veatch; Ernesto Marcelo Sebrié
Journal:  Nicotine Tob Res       Date:  2020-05-26       Impact factor: 4.244

2.  Angel H Roffo: the forgotten father of experimental tobacco carcinogenesis.

Authors:  Robert N Proctor
Journal:  Bull World Health Organ       Date:  2006-06-21       Impact factor: 9.408

3.  A Nicotine-Focused Framework for Public Health.

Authors:  Scott Gottlieb; Mitchell Zeller
Journal:  N Engl J Med       Date:  2017-08-16       Impact factor: 91.245

4.  E-cigarettes: striking the right balance.

Authors:  K Michael Cummings; David Hammond
Journal:  Lancet Public Health       Date:  2020-01-22

5.  Establishing a nicotine threshold for addiction. The implications for tobacco regulation.

Authors:  N L Benowitz; J E Henningfield
Journal:  N Engl J Med       Date:  1994-07-14       Impact factor: 91.245

6.  Epidemiology of the third wave of tobacco litigation in the United States, 1994-2005.

Authors:  Clifford E Douglas; Ronald M Davis; John K Beasley
Journal:  Tob Control       Date:  2006-12       Impact factor: 7.552

7.  Quitting Smoking Among Adults - United States, 2000-2015.

Authors:  Stephen Babb; Ann Malarcher; Gillian Schauer; Kat Asman; Ahmed Jamal
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-01-06       Impact factor: 17.586

Review 8.  The changing public image of smoking in the United States: 1964-2014.

Authors:  K Michael Cummings; Robert N Proctor
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-01       Impact factor: 4.254

9.  Vitamin E Acetate in Bronchoalveolar-Lavage Fluid Associated with EVALI.

Authors:  Benjamin C Blount; Mateusz P Karwowski; Peter G Shields; Maria Morel-Espinosa; Liza Valentin-Blasini; Michael Gardner; Martha Braselton; Christina R Brosius; Kevin T Caron; David Chambers; Joseph Corstvet; Elizabeth Cowan; Víctor R De Jesús; Paul Espinosa; Carolina Fernandez; Cory Holder; Zsuzsanna Kuklenyik; Jennifer D Kusovschi; Cody Newman; Gregory B Reis; Jon Rees; Chris Reese; Lalith Silva; Tiffany Seyler; Min-Ae Song; Connie Sosnoff; Carleen R Spitzer; Denise Tevis; Lanqing Wang; Cliff Watson; Mark D Wewers; Baoyun Xia; Douglas T Heitkemper; Isaac Ghinai; Jennifer Layden; Peter Briss; Brian A King; Lisa J Delaney; Christopher M Jones; Grant T Baldwin; Anita Patel; Dana Meaney-Delman; Dale Rose; Vikram Krishnasamy; John R Barr; Jerry Thomas; James L Pirkle
Journal:  N Engl J Med       Date:  2019-12-20       Impact factor: 91.245

10.  Prevalence of vaping and smoking among adolescents in Canada, England, and the United States: repeat national cross sectional surveys.

Authors:  David Hammond; Jessica L Reid; Vicki L Rynard; Geoffrey T Fong; K Michael Cummings; Ann McNeill; Sara Hitchman; James F Thrasher; Maciej L Goniewicz; Maansi Bansal-Travers; Richard O'Connor; David Levy; Ron Borland; Christine M White
Journal:  BMJ       Date:  2019-06-20
View more
  1 in total

1.  Trends and Patterns of Tobacco and Nicotine Product Use Among Youth in Canada, England, and the United States From 2017 to 2019.

Authors:  Katherine A East; Jessica L Reid; Vicki L Rynard; David Hammond
Journal:  J Adolesc Health       Date:  2021-04-08       Impact factor: 7.830

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.